Showing results (131-140 of 173) with videos related to
Sort By:
Pageof 18
Endocrinology, Diabetes & Metabolism|September 10, 2021
Oxy210, a novel inhibitor of hedgehog and TGF-β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in miceSimon T Hui, Feng Wang, Frank Stappenbeck, et al.Biomolecules|July 28, 2026
Combined Pharmacologic and Nutritional Modulation of High-Fat Diet-Associated Tumor-Supportive Features in Prostate Cancer ModelsKe Wu, Qiongyu Hao, Joshua Yang, et al.Orvosi Hetilap|August 30, 2000
[Parvovirus B19 infection in hydrops fetalis]L Kaiser, F Sükösd, B Veszprémi, et al.The American Journal of Physiology|May 18, 1999
In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibitionY Zhang, J M Norian, C E Magyar, et al.Endocrinology|March 16, 2004
Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragmentsW Bruce Sneddon, Clara E Magyar, Gordon E Willick, et al.International Journal of Cancer|September 15, 1979
The value of a sensitive assay of carcino-placental alkaline phosphatase (CPAP) in the follow-up of gynecological cancersW G Haije, J H Meerwaldt, A Talerman, et al.Biochemical Pharmacology|June 30, 2006
Green tea flavonols inhibit glucosidase IIAlessandra Gamberucci, Laura Konta, Angela Colucci, et al.Biochimica Et Biophysica Acta|May 1, 2007
Transport and transporters in the endoplasmic reticulumMiklós Csala, Paola Marcolongo, Beáta Lizák, et al.Cancer Research|December 17, 2010
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migrationJi Wang, Robert F Place, Vera Huang, et al.Cancer Research|February 9, 2013
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinomaJiabin An, Huiren Liu, Clara E Magyar, et al.Pageof 18